Drug delivery in soft tissue engineering

Expert Opinion on Drug Delivery

Volumn 8, Issue 9, 2011, Pages 1175-1188

  Ladewig, Katharina ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Biomaterials; Growth factors; Hydrogels; Soft tissue engineering

Indexed keywords

BECAPLERMIN; BIOMATERIAL; FIBRONECTIN; GROWTH FACTOR; MORPHOGEN; TISSUE SCAFFOLD;

BIODEGRADABILITY; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; ENCAPSULATION; FOOD AND DRUG ADMINISTRATION; HYDROGEL; IMMOBILIZATION; MATRIX ATTACHMENT REGION; REVIEW; SOFT TISSUE; TISSUE ENGINEERING;

ANIMALS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GROWTH SUBSTANCES; HUMANS; HYDROGELS; IMMOBILIZED PROTEINS; REGENERATIVE MEDICINE; SOFT TISSUE INJURIES; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 80052089727     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.588698     Document Type: Review

References (152)

1. Langer R, Vacanti J. Tissue engineering. Science 1993;260(5110):920-6 (Pubitemid 23209960)
2. Langer R. Tissue engineering. Mol Ther 2000;1(1):12-15
3. Altomare L, Fare S. Cells response to topographic and chemical micropatterns. J Appl Biomater Biomech 2008;6(3):132-43.
4. Cortese B, Gigli G, Riehle M. Mechanical gradient cues for guided cell motility and control of cell behavior on uniform substrates. Adv Funct Mater 2009;19(18):2961-8
5. Cosgrove BD, Griffith LG, Lauffenburger DA. Fusing tissue engineering and systems biology toward fulfilling their promise. Cell Mol Bioeng 2008;1(1):33-41
6. Galler KM, Dsouza RN, Hartgerink JD. Biomaterials and their potential applications for dental tissue engineering. J Mater Chem 2010;20(40):8730-46
7. Hajicharalambous CS, Lichter J, Hix WT, et al. Nano- and sub-micron porous polyelectrolyte multilayer assemblies: biomimetic surfaces for human corneal epithelial cells. Biomaterials 2009;30(23-24):4029-36
8. Hoffmann JC, West JL. Three-dimensional photolithographic patterning of multiple bioactive ligands in poly(ethylene glycol) hydrogels. Soft Matter 2010;6(20):5056-63
9. Kim DH, Seo CH, Han K, et al. Guided cell migration on microtextured substrates with variable local density and anisotropy. Adv Funct Mater 2009;19(10):1579-86.
10. Leach JB, Brown XQ, Jacot JG, et al. Neurite outgrowth and branching of PC12 cells on very soft substrates sharply decreases below a threshold of substrate rigidity. J Neural Eng 2007;4(2):26-34 (Pubitemid 46603794)
11. Li XR, MacEwan MR. Xie JW, et al. fabrication of density gradients of biodegradable polymer microparticles and their use in guiding neurite outgrowth. Adv Funct Mater 2010;20(10):1632-7
12. Mirakaj V, Brown S, Laucher S, et al. Repulsive guidance molecule-A (RGM-A) inhibits leukocyte migration and mitigates inflammation. Proc Natl Acad Sci USA 2011;108(16):6555-60
13. Sant S, Hancock MJ, Donnelly JP, et al. Biomimetic gradient hydrogels for tissue engineering. Can J Chem Eng 2010;88(6):899-911
14. Tate MC, Shear DA, Hoffman SW, et al. Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transplant 2002;11(3):283-95. (Pubitemid 34665829)
15. Thibault MM, Hoemann CD, Buschmann MD. Fibronectin, vitronectin, and collagen I induce chemotaxis and haptotaxis of human and rabbit mesenchymal stem cells in a standardized transmembrane assay. Stem Cells Dev 2007;16(3):489-502 (Pubitemid 47016234)
16. Yang F, Cho SW. Son SM, et al. combinatorial extracellular matrices for human embryonic stem cell differentiation in 3D. Biomacromolecules 2010;11(8):1909-14
17. Vashi AV, Keramidaris E, Abberton KM, et al. Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials 2007;29(5):573-9
18. Vashi AV, Abberton KM, Thomas GP, et al. Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. Tissue Eng 2006;12(11):3035-43 (Pubitemid 44846409)
19. Reddi AH. Growth factors and morphogens: signals for tissue engineering, In: Tissue Engineering, Fischer JP, Mikos AG, Bronzino JD. (Eds.), 2007, CRC Press, Boca Raton, USA, p. 2-1-2-5
20. Ahmed TAE, Giulivi A, Griffith M, et al. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Tissue Eng 2011;17(3-4):323-35
21. Wheeldon I, Farhadi A, Bick AG, et al. Nanoscale tissue engineering: spatial control over cell-materials interactions. Nanotechnology 2011;22:21; doi: 10.1088/0957-4484/22/ 21/212001
22. Ito A, Mase A, Takizawa Y, et al. Transglutaminase-mediated gelatin matrices incorporating cell adhesion factors as a biomaterial for tissue engineering. J Biosci Bioeng 2003;95(2):196-9 (Pubitemid 36313203)
23. Jurga M, Dainiak MB, Sarnowska A, et al. The performance of laminin-containing cryogel scaffolds in neural tissue regeneration. Biomaterials 2011;32(13):3423-34
24. Munarin F, Guerreiro SG, Grellier MA, et al. Pectin-based injectable biomaterials for bone tissue engineering. Biomacromolecules 2011;12(3):568-77
25. Fittkau MH, Zilla P, Bezuidenhout D, et al. The selective modulation of endothelial cell mobility on RGD peptide containing surfaces by YIGSR peptides. Biomaterials 2005;26(2):167-74 (Pubitemid 38789099)
26. Feng Y, Zhao H, Zhang L, et al. Surface modification of biomaterials by photochemical immobilization and photograft polymerization to improve hemocompatibility. Front Chem Eng China 2010;4(3):372-81
27. Mourino V, Boccaccini AR. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface 2010;7(43):209-27
28. Stayton PS, El-Sayed MEH, Murthy N, et al. Smart delivery systems for biomolecular therapeutics. Orthod Craniofac Res 2005;8(3):219-25
29. Plank C, Scherer F, Rudolph C. Localized nucleic acid delivery: a discussion of selected methods. In: Schleef M, editor. DNA-Pharmaceuticals. Wiley-VCH Verlag GmbH & Co. KGaA; 2006. p. 55-116.
30. Shea L, Smiley E, Bonadio J, et al. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 1999;17(6):551-4 (Pubitemid 29262917)
31. Van Blitterswijk CA. Tissue engineering. amsterdam. Elsevier/Academic Press; London: 2008
32. Fu Y, Kao WJ. Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems. Expert Opin Drug Deliv 2010;7(4):429-44
33. Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues. State of the art and future perspectives. J Biomater Sci Polym Ed 2001;12(1):107-24 (Pubitemid 32335467)
34. Duan B, Wang M. Customized Ca-P/ PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor. J R Soc Interface 2010;7(Suppl 5):S615-29
35. Biondi M, Indolfi L, Ungaro F, et al. Bioactivated collagen-based scaffolds embedding protein-releasing biodegradable microspheres: tuning of protein release kinetics. J Mater Sci Mater Med 2009;20(10):2117-28
36. Biondi M, Ungaro F, Quaglia F, et al. Controlled drug delivery in tissue engineering. Adv Drug Deliv Rev 2008;60(2):229-42 (Pubitemid 350236401)
37. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 2001;101(7):1869-79 (Pubitemid 35377789)
38. Malafaya PB, Silva GA, Reis RL. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 2007;59(4-5):207-33 (Pubitemid 46879967)
39. Sokolsky-Papkov M, Agashi K, Olaye A, et al. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59(4-5):187-206 (Pubitemid 46887622)
40. Nillesen STM, Geutjes PJ, Wismans R, et al. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 2006;28(6):1123-31 (Pubitemid 44809425)
41. Taylor SJ, McDonald JW III, Sakiyama-Elbert SE. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release 2004;98(2):281-94 (Pubitemid 38950737)
42. Lee AC, Yu VM, Lowe JB, et al. Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol 2003;184(1):295-303 (Pubitemid 37444039)
43. Wissink MJB, Beernink R, Pieper JS, et al. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials 2001;22(16):2291-9 (Pubitemid 32591363)
44. Sakiyama-Elbert SE, Hubbell JA. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000;65(3):389-402 (Pubitemid 30122941)
45. Lee H, Park TG. Design principles in biomaterials and scaffolds. Found Regener Med 2010;312-25
46. Sellke FW, Laham RJ, Edelman ER, et al. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 1998;65(6):1540-4
47. Laham RJ, Sellke FW, Edelman ER, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 1999;100(18):1865-71 (Pubitemid 29511139)
48. Lee K, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 2011;8(55):153-70
49. Jeon O, Song SJ, Kang S-W, et al. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-coglycolic acid) scaffold. Biomaterials 2007;28(17):2763-71 (Pubitemid 46413347)
50. Mann BK, Schmedlen RH, West JL. Tethered-TGF-beta1 increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 2001;22(5):439-44 (Pubitemid 32007848)
51. Kuhl PR, Griffith-Cima LG. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nat Med 1996;2(9):1022-7 (Pubitemid 26306842)
52. Zisch AH, Lutolf MP, Ehrbar M, et al. Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. FASEB J 2003;17(15):2260-2 (Pubitemid 39561459)
53. Moore K, Macsween M, Shoichet M. Immobilized concentration gradients of neurotrophic factors guide neuriteo outgrowth of primary neurons in macroporous scaffolds. Tissue Eng 2006;12(2):267-78
54. Thomasin C, Corradin G, Men Y, et al. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/ poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response. J Control Release 1996;41(1-2):131-45 (Pubitemid 26246370)
55. Sanchez A, Gupta RK, Alonso MJ, et al. Pulsed controlled-release system for potential use in vaccine delivery. J Pharm Sci 1996;85(6):547-52 (Pubitemid 26179093)
56. Hilbert AK, Fritzsche U, Kissel T. Biodegradable microspheres containing influenza A vaccine: immune response in mice. Vaccine 1999;17(9-10):1065-73 (Pubitemid 29132938)
57. Cleland JL, Barron L, Berman PW, et al. Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response. J Pharm Sci 1996;85(12):1346-9 (Pubitemid 27014192)
58. Cleland JL, Duenas ET, Park A, et al. Development of poly-(d,l-lactide- coglycolide) microsphere formulations containing recombinant human vascular endothelial growth factor to promote local angiogenesis. J Control Release 2001;72(1-3):13-24 (Pubitemid 32522340)
59. Cleland JL, Lim A, Daugherty A, et al. Development of a single-shot subunit vaccine for HIV-1 with programmable in vivo autoboost and long-lasting neutralizing response. J Pharm Sci 1998;87(12):1489-95
60. Rizzi SC, Ehrbar M, Halstenberg S, et al. Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules 2006;7(11):3019-29 (Pubitemid 46039956)
61. Van Tomme SR, Hennink WE. Biodegradable dextran hydrogels for protein delivery applications. Expert Rev Med Devices 2007;4(2):147-64 (Pubitemid 46522765)
62. Franssen O, Stenekes RJH, Hennink WE. Controlled release of a model protein from enzymatically degrading dextran microspheres. J Control Release 1999;59(2):219-28 (Pubitemid 29199927)
63. Kost J, Langer R. Responsive polymeric delivery systems. Adv Drug Deliv Rev 2001;46(1-3):125-48 (Pubitemid 33653418)
64. Davis KA, Anseth KS. Controlled release from crosslinked degradable networks. Crit Rev Ther Drug Carrier Syst 2002;19(4 & 5):385-423 (Pubitemid 36314478)
65. Liu X, Pettway GJ, McCauley LK, et al. Pulsatile release of parathyroid hormone from an implantable delivery system. Biomaterials 2007;28(28):4124-31 (Pubitemid 47048374)
66. Jain JP, Modi S, Domb AJ, et al. Role of polyanhydrides as localized drug carriers. J Control Release 2005;103(3):541-63 (Pubitemid 40476140)
67. Kumar N, Langer RS, Domb AJ. Polyanhydrides: an overview. Adv Drug Deliv Rev 2002;54(7):889-910
68. Tabata Y, Gutta S, Langer R. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm Res 1993;10(4):487-96 (Pubitemid 23113038)
69. Torres MP, Determan AS, Anderson GL, et al. Amphiphilic polyanhydrides for protein stabilization and release. Biomaterials 2006;28(1):108-16
70. Grayson ACR, Choi IS, Tyler BM, et al. Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater 2003;2(11):767-72
71. Peppas NA, Bures P, Leobandung W, et al. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 2000;50(1):27-46 (Pubitemid 30326687)
72. Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today 2002;7(10):569-79 (Pubitemid 34603648)
73. Miyata T, Uragami T, Nakamae K. Biomolecule-sensitive hydrogels. Adv Drug Deliv Rev 2002;54(1):79-98 (Pubitemid 34075315)
74. Ishihara K, Kobayashi M, Ishimaru N, et al. Glucose-induced permeation control of insulin through a complex membrane consisting of immobilized glucose oxidase and a polyamine. Polym J (Tokyo) 1984;16(8):625-31 (Pubitemid 14664271)
75. Byrne ME, Salian V. Molecular imprinting within hydrogels II: progress and analysis of the field. Int J Pharm 2008;364(2):188-212
76. Prabaharan M, Tiwari A, Li S. Polysaccharides/poly(Nisopropylacrylamide)- based stimuli-responsive hydrogels as novel biomaterials. Smart Polym Mater Biomed Appl 2010;33-56
77. Kumari P, Tiwari A, Prabaharan M, et al. Smart polymeric materials emerging for biological applications. Smart Polym Mater Biomed Appl 2010;103-18
78. Banerjee S, Chaurasia G, Ghosh A. Smart polymers: around the cosmos. Biochim Biophys Acta 2010;3(3):135-41
79. Kulkarni RV, Biswanath S. Electrically responsive smart hydrogels in drug delivery: a review. J Appl Biomater Biomech 2007;5(3):125-39 (Pubitemid 351495456)
80. Hafeli UO. Magnetically modulated therapeutic systems. Int J Pharm 2004;277(1-2):19-24 (Pubitemid 38670417)
81. Katz JS, Burdick JA. Light-responsive biomaterials: development and applications. Macromol Biosci 2010;10(4):339-48
82. Brayfield CA, Marra KG, Rubin JP. Adipose tissue regeneration. Curr Stem Cell Res Ther 2010;5(2):116-21
83. Choi JH, Gimble JM, Lee K, et al. Adipose tissue engineering for soft tissue regeneration. Tissue Eng Part B Rev 2010;16(4):413-26
84. Katz AJ, Llull R, Hedrick MH, et al. Emerging approaches to the tissue engineering of fat. Clin Plast Surg 1999;26(4):587-603; viii (Pubitemid 29494161)
85. Patrick CW Jr. Tissue engineering strategies for adipose tissue repair. Anat Rec 2001;263(4):361-6 (Pubitemid 32730263)
86. Stosich MS, Mao JJ. Adipose tissue engineering from human adult stem cells: clinical implications in plastic and reconstructive surgery. Plast Reconstr Surg 2006;119(1):71-83
87. Tanzi MC, Fare S. Adipose tissue engineering: state of the art, recent advances and innovative approaches. Expert Rev Med Devices 2009;6(5):533-51
88. Bauer-Kreisel P, Goepferich A, Blunk T. Cell-delivery therapeutics for adipose tissue regeneration. Adv Drug Deliv Rev 2010;62(7-8):798-813
89. Kawaguchi N, Toriyama K, Nicodemou-Lena E, et al. De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor. Proc Natl Acad Sci USA 1998;95(3):1062-6 (Pubitemid 28124912)
90. Tabata Y, Miyao M, Inamoto T, et al. De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. Tissue Eng 2000;6(3):279-89 (Pubitemid 30419210)
91. Kimura Y, Ozeki M, Inamoto T, et al. Time course of de Novo adipogenesis in Matrigel by gelatin microspheres incorporating basic fibroblast growth factor. Tissue Eng 2002;8(4):603-13 (Pubitemid 34857797)
92. Yuksel E, Weinfeld AB, Cleek R, et al. De novo adipose tissue generation through long-term, local delivery of insulin and insulin-like growth factor-1 by PLGA/PEG microspheres in an in vivo rat model: a novel concept and capability. Plast Reconstr Surg 2000;105(5):1721-9 (Pubitemid 30191277)
93. Yuksel E, Weinfeld AB, Cleek R, et al. Increased free fat-graft survival with the long-term, local delivery of insulin, insulin-like growth factor-I, and basic fibroblast growth factor by PLGA/PEG microspheres. Plast Reconstr Surg 2000;105(5):1712-20 (Pubitemid 30191276)
94. Masuda T, Furue M, Matsuda T. Photocured, Styrenated gelatin-based microspheres for de novo adipogenesis through corelease of basic fibroblast growth factor, insulin, and insulin-like growth factor I. Tissue Eng 2004;10(3/4):523-35 (Pubitemid 38580273)
95. Kelly JL, Findlay MW, Knight KR, et al. Contact with existing adipose tissue is inductive for adipogenesis in matrigel. Tissue Eng 2006;12(7):2041-7 (Pubitemid 44162861)
96. Hemmrich K, Thomas GPL, Abberton KM, et al. Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity. Obesity (Silver Spring) 2007;15(12):2951-7. (Pubitemid 351256656)
97. Rophael JA, Craft RO, Palmer JA, et al. Angiogenic growth factor synergism in aa murine tissue engineering model of angiogenesis and adipogenesis. Am J Pathol 2007;171(6):2048-57
98. Stillaert F, Findlay M, Palmer J, et al. Host rather than graft origin of Matrigel-induced adipose tissue in the murine tissue-engineering chamber. Tissue Eng 2007;13(9):2291-300 (Pubitemid 47404444)
99. Dolderer JH, Abberton KM, Thompson EW, et al. Spontaneous large volume adipose tissue generation from a vascularized pedicled fat flap inside a chamber space. Tissue Eng 2007;13(4):673-81 (Pubitemid 46651498)
100. Abberton KM, Bortolotto SK, Woods AA, et al. Myogel, a novel, basement membrane-rich, extracellular matrix derived from skeletal muscle, is highly adipogenic in vivo and in vitro. Cells Tissues Organs 2008;188(4):347-58
101. Thomas GPL, Hemmrich K, Abberton KM, et al. Zymosan-induced inflammation stimulates neo-adipogenesis. Int J Obes 2008;32(2):239-48 (Pubitemid 351271773)
102. Findlay MW, Messina A, Thompson EW, et al. Long-term persistence of tissue-engineered adipose flaps in a murine model to 1 year: an update. Plast Reconstr Surg 2009;124(4):1077-84
103. Hamid ZAA, Blencowe A, Ozcelik B, et al. Epoxy-amine synthesised hydrogel scaffolds for soft-tissue engineering. Biomaterials 2010;31(25):6454-67
104. Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2002;54(1):3-12 (Pubitemid 34081178)
105. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003;24(24):4337-51. (Pubitemid 36960132)
106. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007;100(9):1249-60 (Pubitemid 46742916)
107. Uriel S, Huang J-J, Moya ML, et al. The role of adipose protein derived hydrogels in adipogenesis. Biomaterials 2008;29(27):3712-19
108. Zustiak SP, Leach JB. Hydrolytically degradable Poly(Ethylene Glycol) hydrogel scaffolds with tunable degradation and mechanical properties. Biomacromolecules 2010;11(5):1348-57
109. Ladewig K, OConnor AJ. Designing bioreactors for in vivo soft tissue engineering. Tissue Eng Biomater 2011; submitted
110. Chen RR, Silva EA, Yuen WW, et al. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 2007;24(2):258-64 (Pubitemid 46072185)
111. Chen F-M, Zhang M, Wu Z-F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010;31(24):6279-308 . Reviews strategies for the spatially and temporally accurate delivery of multiple growth factors.
112. Richardson TP, Peters MC, Ennett AB, et al. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001;19(11):1029-34 (Pubitemid 33041886)
113. Wieland JA, Houchin-Ray TL, Shea LD. Non-viral vector delivery from poly (ethylene glycol)-hyaluronic acid hydrogels. J Control Release 2007;120(3):233-41 (Pubitemid 47058636)
114. Huang Y-C, Kaigler D, Rice KG, et al. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 2005;20(5):848-57 (Pubitemid 40571642)
115. Lu Y, Shansky J, Del Tatto M, et al. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 2001;104(5):594-9 (Pubitemid 32738131)
116. Tyrone JW, Mogford JE, Chandler LA, et al. Collagen-embedded platelet-derived growth factor dna plasmid promotes wound healing in a dermal ulcer model. J Surg Res 2000;93(2):230-6
117. Ladewig K, Niebert M, Xu ZP, et al. Controlled preparation of layered double hydroxide nanoparticles and their application as gene delivery vehicles. Appl Clay Sci 2010;48(1-2):280-9
118. Ladewig K, Niebert M, Xu ZP, et al. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles. Biomaterials 2010;31(7):1821-9
119. Ladewig K, Xu ZP, Lu GQ. Layered double hydroxide nanoparticles in gene and drug delivery. Expert Opin Drug Deliv 2009;6(9):907-22
120. Cohen-Sacks H, Elazar V, Gao J, et al. Delivery and expression of pDNA embedded in collagen matrices. J Control Release 2004;95(2):309-20 (Pubitemid 38230045)
121. Lim HJ, Ghim HD, Choi JH, et al. Controlled release of BMP-2 from alginate nanohydrogels enhanced osteogenic differentiation of human bone marrow stromal cells. Macromol Res 2010;18(8):787-92
122. Nakamura M, Iwanaga S, Henmi C, et al. Biomatrices and biomaterials for future developments of bioprinting and biofabrication. Biofabrication 2010;2(1):014110/1-6
123. Song Q. Application of artificial biomaterials to tendon injury. Zhongguo Zuzhi Gongcheng Yanjiu Yu Linchuang Kangfu 2010;14(12):2233-6
124. Swetha M, Sahithi K, Moorthi A, et al. Biocomposites containing natural polymers and hydroxyapatite for bone tissue engineering. Int J Biol Macromol 2010;47(1):1-4
125. Dutta J, Dutta PK. Chitin and chitosan: the unique smart biomaterials for biomedical applications. Smart Polym Mater Biomed Appl 2010;307-35
126. Jayakumar R, Prabaharan M, Nair SV, et al. Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applications. Prog Mater Sci 2010;55(7):675-709
127. Shi C, Zhu Y, Ran X, et al. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 2006;133(2):185-92
128. Lee JE, Kim SE, Kwon IC, et al. Effects of a chitosan scaffold containing TGF-beta1 encapsulated chitosan microspheres on in vitro chondrocyte culture. Artif Organs 2004;28(9):829-39
129. Lutolf MP, Lauer-Fields JL, Schmoekel HG, et al. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics. Proc Natl Acad Sci USA 2003;100(9):5413-18 (Pubitemid 36542719)
130. Ye Q, Zund G, Benedikt P, et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000;17(5):587-91 (Pubitemid 30256271)
131. Yin M, Zhao Z, Zhang J. Construction of tissue-engineered blood vessel stent using different materials: characteristics and effectiveness. Zhongguo Zuzhi Gongcheng Yanjiu Yu Linchuang Kangfu 2010;14(16):2958-62
132. Mandal BB, Mann JK, Kundu SC. Silk fibroin/gelatin multilayered films as a model system for controlled drug release. Eur J Pharm Sci 2009;37(2):160-71
133. Bozzini S, Petrini P, Altomare L, et al. Fabrication of chemically cross-linked porous gelatin matrices. J Appl Biomater Biomech 2009;7(3):194-9
134. Duflo S, Thibeault SL, Li W, et al. Vocal fold tissue repair in vivo using a synthetic extracellular matrix. Tissue Eng 2006;12(8):2171-80 (Pubitemid 44734976)
135. Segura T, Anderson BC, Chung PH, et al. Crosslinked hyaluronic acid hydrogels: a strategy to functionalize and pattern. Biomaterials 2005;26(4):359-71 (Pubitemid 38951103)
136. Mandal A, Panigrahi S, Zhang C. Collagen as biomaterial for medical application-drug delivery and scaffolds for tissue regeneration: a review. Biol Eng 2010;2(2):63-88
137. Parenteau-Bareil R, Gauvin R, Berthod F. Collagen-based biomaterials for tissue engineering applications. Materials 2010;3:1863-87
138. Burgess BT, Myles JL, Dickinson RB. Quantitative analysis of adhesion-mediated cell migration in three-dimensional gels of RGD-grafted collagen. Ann Biomed Eng 2000;28(1):110-18 (Pubitemid 30563023)
139. Pachence JM. Collagen-based devices for soft tissue repair. J Biomed Mater Res 1996;33(1):35-40 (Pubitemid 26094605)
140. Shi X, Wang Y, Varshney RR, et al. Microsphere-based drug releasing scaffolds for inducing osteogenesis of human mesenchymal stem cells in vitro. Eur J Pharm Sci 2010;39(1-3):59-67
141. Savarino L, Baldini N, Greco M, et al. The performance of poly-(epsiloncaprolactone) scaffolds in a rabbit femur model with and without autologous stromal cells and BMP4. Biomaterials 2007;28(20):3101-9 (Pubitemid 46661769)
142. Ng KW, Hutmacher DW, Schantz J-T, et al. Evaluation of ultra-thin poly (epsilon-caprolactone) films for tissue-engineered skin. Tissue Eng 2001;7(4):441-55 (Pubitemid 32734776)
143. Grizzi I, Garreau H, Li S, et al. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials 1995;16(4):305-11
144. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005;23(1):47-55 (Pubitemid 41724624)
145. Day RM, Boccaccini AR, Maquet V, et al. In vivo characterization of a novel bioresorbable poly(lactide-co-glycolide) tubular foam scaffold for tissue engineering applications. J Mater Sci Mater Med 2004;15(6):729-34 (Pubitemid 38860252)
146. Suciati T, Howard D, Barry J, et al. Zonal release of proteins within tissue engineering scaffolds. J Mater Sci Mater Med 2006;17(11):1049-56 (Pubitemid 44835991)
147. Holland TA, Tabata Y, Mikos AG. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 2005;101(1-3):111-25 (Pubitemid 39600976)
148. Temenoff JS, Athanasiou KA, LeBaron RG, et al. Effect of poly (ethylene glycol) molecular weight on tensile and swelling properties of oligo (poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res 2002;59(3):429-37 (Pubitemid 34037486)
149. Peter SJ, Lu L, Kim DJ, et al. Effects of transforming growth factor beta-1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates. J Biomed Mater Res 2000;50(3):452-62 (Pubitemid 30180738)
150. Gerhardt L-C, Boccaccini AR. Bioactive glass and glass-ceramic scaffolds for bone tissue engineering. Materials 2010;3:3867-910
151. Alves NM, Leonor IB, Azevedo HS, et al. Designing biomaterials based on biomineralization of bone. J Mater Chem 2010;20(15):2911-21
152. Wu C-J, Gaharwar AK, Schexnailder PJ, et al. Development of biomedical polymer-silicate nanocomposites: a materials science perspective. Materials 2010;3:2986-3005